Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
Article in Molecular Therapy — Oncolytics (August 2023)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Molecular Therapy — Oncolytics (August 2023)
Article in International Journal of Molecular Sciences (July 2023)
Article in International Journal of Molecular Sciences (July 2023)